A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine
Clinical trial NCT05750017 · UNKNOWN
Trial details
- NCT number
- NCT05750017
- Sponsor
- Beijing Luzhu Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2024-02-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.